Literature DB >> 18434123

Peripheral B cell subsets.

David Allman1, Shiv Pillai.   

Abstract

Our understanding of the origins and the biological functions of different peripheral B cell subsets continues to evolve. Some understanding has been obtained regarding the synergy between BCR-derived signals and other receptors and signaling pathways that drive the development of follicular, marginal zone, and B-1 B cells, but this remains a complex and poorly understood issue. More recent information regarding the origins of B-1 and B-2 B cells, the ability of follicular B cells to mature both in the bone marrow and the spleen, the existence of a definable precursor for MZ B cells, and the ability of follicular B cells to occupy two distinct niches are all highlighted in this review.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18434123      PMCID: PMC2532490          DOI: 10.1016/j.coi.2008.03.014

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  53 in total

Review 1.  Regulation of lymphoid development, differentiation, and function by the Notch pathway.

Authors:  Ivan Maillard; Terry Fang; Warren S Pear
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

2.  Perisinusoidal B cells in the bone marrow participate in T-independent responses to blood-borne microbes.

Authors:  Annaiah Cariappa; Irina B Mazo; Catharine Chase; Hai Ning Shi; Haoyuan Liu; Qian Li; Harris Rose; Harry Leung; Bobby J Cherayil; Paul Russell; Ulrich von Andrian; Shiv Pillai
Journal:  Immunity       Date:  2005-10       Impact factor: 31.745

3.  Control of B-cell responses by Toll-like receptors.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Nature       Date:  2005-11-17       Impact factor: 49.962

4.  Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire.

Authors:  J G Cyster; S B Hartley; C C Goodnow
Journal:  Nature       Date:  1994-09-29       Impact factor: 49.962

5.  Evidence of marginal-zone B cell-positive selection in spleen.

Authors:  Lijun Wen; Joni Brill-Dashoff; Susan A Shinton; Masanao Asano; Richard R Hardy; Kyoko Hayakawa
Journal:  Immunity       Date:  2005-09       Impact factor: 31.745

6.  Notch1 augments NF-kappaB activity by facilitating its nuclear retention.

Authors:  Hyun Mu Shin; Lisa M Minter; Ok Hyun Cho; Sridevi Gottipati; Abdul H Fauq; Todd E Golde; Gail E Sonenshein; Barbara A Osborne
Journal:  EMBO J       Date:  2005-12-01       Impact factor: 11.598

7.  Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement.

Authors:  Kalpit A Vora; Elizabeth Nichols; Gene Porter; Yan Cui; Carol Ann Keohane; Richard Hajdu; Jeffery Hale; William Neway; Dennis Zaller; Suzanne Mandala
Journal:  J Leukoc Biol       Date:  2005-05-13       Impact factor: 4.962

8.  B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae.

Authors:  Karen M Haas; Jonathan C Poe; Douglas A Steeber; Thomas F Tedder
Journal:  Immunity       Date:  2005-07       Impact factor: 31.745

9.  Engagement of the antigen-receptor on immature murine B lymphocytes results in death by apoptosis.

Authors:  A Norvell; L Mandik; J G Monroe
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

10.  Characterization of marginal zone B cell precursors.

Authors:  Bhaskar Srivastava; William J Quinn; Kristin Hazard; Jan Erikson; David Allman
Journal:  J Exp Med       Date:  2005-10-31       Impact factor: 14.307

View more
  220 in total

1.  CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitus.

Authors:  Andrew D Vonberg; Maria Acevedo-Calado; Aaron R Cox; Susan L Pietropaolo; Roberto Gianani; Steven K Lundy; Massimo Pietropaolo
Journal:  JCI Insight       Date:  2018-12-06

2.  Immature and transitional B cells are latency reservoirs for a gammaherpesvirus.

Authors:  Carrie B Coleman; Michael S Nealy; Scott A Tibbetts
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

Review 3.  Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils.

Authors:  Stephen J Galli; Niels Borregaard; Thomas A Wynn
Journal:  Nat Immunol       Date:  2011-10-19       Impact factor: 25.606

4.  The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production.

Authors:  Athenia L Oldham; Cathrine A Miner; Hong-Cheng Wang; Carol F Webb
Journal:  Mol Immunol       Date:  2011-10-02       Impact factor: 4.407

Review 5.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

6.  Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen.

Authors:  Bao Hoa Duong; Takayuki Ota; Djemel Aït-Azzouzene; Miyo Aoki-Ota; José Luis Vela; Christoph Huber; Kevin Walsh; Amanda L Gavin; David Nemazee
Journal:  J Immunol       Date:  2010-03-15       Impact factor: 5.422

7.  The actin-bundling protein L-plastin is essential for marginal zone B cell development.

Authors:  Elizabeth M Todd; Lauren E Deady; Sharon Celeste Morley
Journal:  J Immunol       Date:  2011-08-10       Impact factor: 5.422

8.  Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia.

Authors:  Kyoung Eun Lee; Michelle Spata; Lauren J Bayne; Elizabeth L Buza; Amy C Durham; David Allman; Robert H Vonderheide; M Celeste Simon
Journal:  Cancer Discov       Date:  2015-12-29       Impact factor: 39.397

9.  Presentation of high antigen-dose by splenic B220(lo) B cells fosters a feedback loop between T helper type 2 memory and antibody isotype switching.

Authors:  Jason S Ellis; F Betul Guloglu; Habib Zaghouani
Journal:  Immunology       Date:  2016-01-28       Impact factor: 7.397

Review 10.  B-1 B cell development in the fetus and adult.

Authors:  Encarnacion Montecino-Rodriguez; Kenneth Dorshkind
Journal:  Immunity       Date:  2012-01-27       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.